HLA ‐antibody testing female donors with a pregnancy history augments the low titer group O whole blood supply
Year: 2026
Type: article
Abstract: BACKGROUND: Low titer group O whole blood (LTOWB) use across the United States is increasing. This simulation calculated the number of female donors who would qualify for LTOWB donation if HLA-antibody screening was implemented in different strategies. METHODS: Using US nativity data and information on blood donors from 2023, a model was constructed that calculated how many of these donors would be males and nulliparous females, neither of which require HLA-antibody screening before LTOWB donation. The model then calculated how many parous females would be HLA-antibody sensitized based on each woman's parity in three antibody screening scenarios: all parous women, all parous women ≥50 years old, and all parous women older than the 99th percentile of the age of final birth. These calculations were performed for RhD-negative and RhD-positive donors. RESULTS: The model calculated that there would be 222,239 RhD-negative male and 74,655 nulliparous RhD-negative female donors. If all group O RhD-negative parous females were screened, 109,479 were calculated to not be HLA-sensitized for a total of 406,373 LTOWB eligible donors. If only the group O RhD-negative females ≥50 years were screened, 59,138 donors would not be HLA-sensitized for a total of 356,032 LTOWB eligible donors. If only the group O RhD-negative females ≥42 years, the 99th percentile for last birth age, were screened, 80,375 donors would not be HLA-sensitized for a total of 377,269 LTOWB eligible donors. Higher numbers of LTOWB donors were realized when RhD-positive males and females were modeled. CONCLUSION: HLA-antibody screening realizes additional LTOWB donors.
Source: Transfusion
DOI: 10.1111/trf.70485
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,100
OpenAlex ID: W7228923660
